'Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients': by Andrew Dodson1,2 , Suzanne Parry3 , Merdol Ibrahim3 , John MS Bartlett4 , Sarah Pinder5 , Mitch Dowsett1,2 and Keith Miller3 , J Pathol Clin Res 2018; 4: 262-273, https://doi.org/10.1002/cjp2.112
- PMID: 32633474
- PMCID: PMC7339178
- DOI: 10.1002/cjp2.173
'Breast cancer biomarkers in clinical testing: analysis of a UK NEQAS ICC & ISH database containing results from 199 300 patients': by Andrew Dodson1,2 , Suzanne Parry3 , Merdol Ibrahim3 , John MS Bartlett4 , Sarah Pinder5 , Mitch Dowsett1,2 and Keith Miller3 , J Pathol Clin Res 2018; 4: 262-273, https://doi.org/10.1002/cjp2.112
Erratum for
-
Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients.J Pathol Clin Res. 2018 Oct;4(4):262-273. doi: 10.1002/cjp2.112. Epub 2018 Sep 21. J Pathol Clin Res. 2018. PMID: 30066480 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
